Skip to main content
ResMed Inc. (ASX:RMD)
Australia flag Australia · Delayed Price · Currency is AUD
38.81
+1.00 (2.64%)
At close: Dec 5, 2025

ResMed Revenue

ResMed had revenue of $1.34B USD in the quarter ending September 30, 2025, with 9.07% growth. This brings the company's revenue in the last twelve months to $5.26B, up 9.36% year-over-year. In the fiscal year ending June 30, 2025, ResMed had annual revenue of $5.15B with 9.84% growth.

Revenue (ttm)
$5.26B
Revenue Growth
+9.36%
P/S Ratio
7.09
Revenue / Employee
$495.98K
Employees
10,600
Market Cap
56.38B AUD

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 20255.15B461.03M9.84%
Jun 30, 20244.69B462.30M10.95%
Jun 30, 20234.22B644.87M18.02%
Jun 30, 20223.58B381.30M11.93%
Jun 30, 20213.20B239.81M8.11%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CSL Limited 23.73B
Pro Medicus 212.98M
Cochlear 2.34B
Sonic Healthcare 9.65B
Ramsay Health Care 17.79B
Ansell 3.06B
Telix Pharmaceuticals 1.01B
Mesoblast 26.23M
Revenue Rankings

ResMed News

More News